Iloprost

🧮 Dose calculator

Severe frostbite · Regimen source: FDA Aurlumyn · 2.1FDA Aurlumyn · 2.3

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Aurlumyn · 8.1

  “Risk Summary There are no available data with AURLUMYN during pregnancy to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingDangerous / avoid

  Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Aurlumyn · 8.2

  “Because of the potential for serious adverse reactions, advise women not to breastfeed during treatment with iloprost [see Warnings and Precautions ( 5 ) and Adverse Reactions ( 6 )] .”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Aurlumyn · 8.4

  “Safety and efficacy in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Aurlumyn · 8.5

  “In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.